clorazepate dipotassium has been researched along with 1-methyl-beta-carboline-3-carboxylic acid in 1 studies
| Studies (clorazepate dipotassium) | Trials (clorazepate dipotassium) | Recent Studies (post-2010) (clorazepate dipotassium) | Studies (1-methyl-beta-carboline-3-carboxylic acid) | Trials (1-methyl-beta-carboline-3-carboxylic acid) | Recent Studies (post-2010) (1-methyl-beta-carboline-3-carboxylic acid) |
|---|---|---|---|---|---|
| 325 | 90 | 11 | 53 | 0 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belzung, C; Chapouthier, G; Dodd, RH; Misslin, R; Vogel, E | 1 |
1 other study(ies) available for clorazepate dipotassium and 1-methyl-beta-carboline-3-carboxylic acid
| Article | Year |
|---|---|
Anxiogenic effects of methyl-beta-carboline-3-carboxylate in a light/dark choice situation.
Topics: Animals; Anxiety; Benzodiazepines; Carbolines; Choice Behavior; Clorazepate Dipotassium; Darkness; Dose-Response Relationship, Drug; Flumazenil; Light; Male; Mice | 1987 |